Importance of inflammation in dry eye

Article

A more dynamic therapeutic approach is needed

According to Prof. Stefano Barabino (Clinica Oculistica, University of Genoa, Italy) our approach to dry eye must take into account the fact that it is an inflammatory disorder. In his presentation at the World Ophthalmology Congress in Abu Dhabi, United Arab Emirates, Prof. Barabino discussed the importance of inflammation in the treatment of dry eye.

"First of all," Prof. Barabino said, "when we are talking about dry eye we should keep in mind that we are dealing with the ocular surface." He went on to explain that the ocular surface comprises the tear film, lacrimal glands, corneal and conjunctival epithelia and the meibomian glands, which all work together to protect the ocular surface.

"However, is it dry eye if there is inflammation on the ocular surface," he questioned. "The majority of you will think the answer is yes... so why would you be correct?"

In 2005, Prof. Barabino and the team of Prof. Reza Dana conducted an investigation at the Schepens Eye Research Institute, Harvard University, Boston, USA, on mice in a controlled-environment chamber to determine what effect low-humidity and air flow would have on ocular surface signs.1 These mice developed dry eye to a statistically significant level when compared with a control group of mice. In particular, they demonstrated that fluorescein corneal staining was increased, and that surprisingly tear secretion was decreased after 7 days of exposure to the controlled environment. Also, based on the technique previously developed by the group, the cornea of mice was studied for immunological cells.

Prof. Barabino said, "We used specific markers for macrophages and dendritic cells in these mice corneas and we found that in the periphery and also the centre of the cornea, there is an increased number of these cells, which indicated the presence of an activation of immunological cells in the cornea in mice with dry eye disease."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.